Bass, Berry & Sims attorney Angela Humphreys commented on the significance of the June 2021 private equity (PE) acquisition of Medline, a medical supply company. Three private equity firms—Blackstone Group, Carlyle and Hellman & Friedman—purchased Medline in a transaction valuing the company at more than $30 billion.

“The Medline transaction signals private equity’s continued confidence in the healthcare sector, both in the U.S. and globally,” said Angela. “The infusion of capital will allow Medline to accelerate the expansion of its international operations and supply chain,” she added, noting the federal tax law changes on the horizon.

The full article, “Medline Buyout May Set Off Private Equity Investment Wave,” was published by Modern Healthcare on June 7 and is available online.